Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 2Phase 3 1Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Hodgkin Disease 8Recurrence 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia 6Burkitt Lymphoma 6Myelodysplastic Syndromes 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Neuroblastoma 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Dendritic Cell Sarcoma, Interdigitating 4Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Retinoblastoma 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3

Interventions

Etoposide 3trioctyl phosphine oxide 2indolepropanol phosphate 2Topotecan 2Melphalan 2Ifosfamide 2Cyclophosphamide 2Busulfan 2Whole-Body Irradiation 1Vincristine 1Transplantation 1Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Heparin 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Gelclair 1Filgrastim 1Electroacupuncture 1Doxorubicin 1Carmustine 1Carboplatin 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neuroectodermal Tumors, Primitive, Peripheral × Melphalan × Clear all
NCT00536601 2021-04-22

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase NA Completed
174 enrolled 17 charts
CNSDermatologicGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Neuroblastoma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡